Negative pressure wound therapy for high-risk wounds in lower extremity revascularization: study protocol for a randomized controlled trial

Patrick Murphy, Kevin Lee, Luc Dubois, Guy DeRose, Thomas Forbes, Adam Power, Patrick Murphy, Kevin Lee, Luc Dubois, Guy DeRose, Thomas Forbes, Adam Power

Abstract

Background: Rates of surgical site infections (SSIs) following groin incision for femoral artery exposure are much higher than expected of a clean operation. The morbidity and mortality is high, particularly with the use of prosthetic grafts. The vascular surgery population is at an increased risk of SSIs related to peripheral vascular disease (PVD), diabetes, obesity, previous surgery and presence of tissue loss. Negative pressure wound therapy (NPWT) dressings have been used on primarily closed incisions to reduce surgical site infections in other surgical disciplines. We have not come across any randomized controlled trials to support the prophylactic use of negative pressure wound therapy in high-risk vascular patients undergoing lower limb revascularization.

Methods/design: In this single-center, prospective randomized controlled trial, patients scheduled for a lower limb revascularization requiring open femoral artery exposure who are at a high risk (BMI > 30 kg/m(2), previous femoral cutdown or Rutherford V or VI category for chronic limb ischemia) will be eligible for the study. A total of 108 groin incisions will be randomized to the use of a negative pressure wound device or standard adhesive gauze dressing. Patients will be followed in hospital and reassessed within the first 30 days postoperatively. The primary outcome is SSI within the first 30 days of surgery and will be determined using the intention-to-treat principle. Secondary outcomes include length of stay, emergency room visits, reoperation, amputation and mortality. A cost analysis will be performed.

Discussion: The trial is expected to define the role of NPWT in SSI prophylaxis for lower limb revascularization in high-risk vascular patients. The results of the study will be used to inform current best practice for perioperative care and the minimization of SSIs.

Trial registration: NCT02084017 , March 2014.

References

    1. Greenblatt DY, Rajamanickam V, Mell MW. Predictors of surgical site infection after open lower extremity revascularization. J Vasc Surg. 2011;54:433–9. doi: 10.1016/j.jvs.2011.01.034.
    1. Lee ES, Santilli SM, Olson MM, Kuskowski MA, Lee JT. Wound infection after infrainguinal bypass operations: multivariate analysis of putative risk factors. Surg Infect (Larchmt) 2000;1:257–63. doi: 10.1089/109629600750067183.
    1. Swinnen J, Chao A, Tiwari A, Crozier J, Vicaretti M, Fletcher J. Vertical or transverse incisions for access to the femoral artery: a randomized control study. Ann Vasc Surg. 2010;24:336–41. doi: 10.1016/j.avsg.2009.07.020.
    1. Lawlor DK, Derose G, Harris KA, Lovell MB, Novick TV, Forbes TL. The role of platelet-rich plasma in inguinal wound healing in vascular surgery patients. Vasc Endovascular Surg. 2011;45:241–5. doi: 10.1177/1538574411399157.
    1. Ploeg AJ, Lardenoye JW, Peeters MP, Hamming JF, Breslau PJ. Wound complications at the groin after peripheral arterial surgery sparing the lymphatic tissue: a double-blind randomized clinical trial. Am J Surg. 2009;197:747–51. doi: 10.1016/j.amjsurg.2008.04.014.
    1. Matatov T, Reddy KN, Doucet LD, Zhao CX, Zhang WW. Experience with a new negative pressure incision management system in prevention of groin wound infection in vascular surgery patients. J Vasc Surg. 2013;57:791–5. doi: 10.1016/j.jvs.2012.09.037.
    1. Culver DH, Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG, et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med. 1991;91:152S–7S. doi: 10.1016/0002-9343(91)90361-Z.
    1. van der Slegt J, Kluytmans JAJW, Mulder PGH, Veen EJ, Ho GH, van der Laan L. Surgical site infection after multiple groin incisions in peripheral vascular surgery. Surg Infect (Larchmt) 2014;15:752–6. doi: 10.1089/sur.2013.253.
    1. Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2008;21:119–23. doi: 10.1053/j.semvascsurg.2008.05.008.
    1. Turtiainen J, Saimanen E, Partio T, Kärkkäinen J, Kiviniemi V, Mäkinen K, et al. Surgical wound infections after vascular surgery: prospective multicenter observational study. Scand J Surg. 2010;99:167–72.
    1. Boltz MM, Hollenbeak CS, Julian KG, Ortenzi G, Dillon PW. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery. 2011;150:934–42. doi: 10.1016/j.surg.2011.04.006.
    1. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control. 2009;37:387–97. doi: 10.1016/j.ajic.2008.12.010.
    1. Dorafshar AH, Franczyk M, Gottlieb LJ, Wroblewski KE, Lohman RF. A prospective randomized trial comparing subatmospheric wound therapy with a sealed gauze dressing and the standard vacuum-assisted closure device. Ann Plast Surg. 2012;69:79–84. doi: 10.1097/SAP.0b013e318221286c.
    1. Webster J, Scuffham P, Sherriff KL, Stankiewicz M, Chaboyer WP. Negative pressure wound therapy for skin grafts and surgical wounds healing by primary intention. Cochrane Database Syst Rev. 2012;4
    1. Pearson A. Historical and changing epidemiology of healthcare-associated infections. J Hosp Infect. 2009;73:296–304. doi: 10.1016/j.jhin.2009.08.016.
    1. Szilagyi D, Smith R, Elliot J, Vrandecic M. Infection in arterial reconstruction with synthetic grafts. Ann Surg. 1972;176:321–33. doi: 10.1097/00000658-197209000-00008.
    1. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314–21. doi: 10.1038/nature07039.
    1. Novak A, Khan WS, Palmer J. The evidence-based principles of negative pressure wound therapy in trauma & orthopedics. Open Orthop J. 2014;8:168–77. doi: 10.2174/1874325001408010168.
    1. Glass GE, Murphy GF, Esmaeili A, Lai L-M, Nanchahal J. Systematic review of molecular mechanism of action of negative-pressure wound therapy. Br J Surg. 2014;101:1627–36. doi: 10.1002/bjs.9636.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever